CANARA HSBC LIFE INS CO L
NSE: CANHLIFEMarket Closed • NSE
Day range
52 week range
CANARA HSBC LIFE INS CO L closed at INR130.37 (-3.24%) on volume 2.71x its 20-day average, trading 21.79% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved -19% QoQ
2026-08-14
DIVIDEND Announced
Dividend - Re 0.40 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.15x
Risks
Stretched Valuation: Trading at a high P/E multiple of 92.5x
Bull case
Market Leadership: Established operational scale in Insurance - Life.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 14 Aug 2026 | Dividend | ₹0.40 / share | — | 14 Aug 2026 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 HDFC Bank LimitedHDFCBANK Open analysis | ₹11.24L | 15.93 | 1.79% | ₹46,355.55 | ₹19,059.72 | -45.69% | +17.23% |
 ICICI Bank LimitedICICIBANK Open analysis | ₹10.03L | 18.06 | 0.86% | ₹32,960.41 | ₹16,276.00 | -35.98% | +12.59% |
 State Bank of IndiaSBIN Open analysis | ₹8.89L | 10.32 | 1.81% | ₹62,915.13 | ₹25,121.00 | -29.09% | +13.56% |
 Bajaj Finance LimitedBAJFINANCE Open analysis | ₹6.11L | 29.36 | 0.56% | ₹13,929.00 | ₹6,081.00 | +17.62% | +27.62% |
 Life Insurance Corporation of IndiaLICI Open analysis | ₹5.03L | 8.37 | 2.54% | ₹2.40L | ₹13,584.00 | +6.76% | +24.00% |
 Kotak Mahindra Bank LimitedKOTAKBANK Open analysis | ₹4.45L | 21.93 | 0.15% | ₹11,266.63 | ₹5,480.00 | -41.22% | +22.54% |
 Axis Bank LimitedAXISBANK Open analysis | ₹4.02L | 14.51 | 0.08% | ₹21,381.52 | ₹7,114.00 | -3.52% | +22.53% |
 Bajaj Finserv Ltd.BAJAJFINSV Open analysis | ₹2.77L | 27.45 | 0.08% | ₹42,036.90 | — | +39.05% | — |
Canara HSBC Life Insurance is an Indian life insurance company, headquartered in Gurugram. In 2008, Canara HSBC Life Insurance was a JV between Canara Bank (51%), HSBC Insurance (Asia Pacific) Holdings Limited (26%) and PNB (23%). In 2022, the company renamed itself as Canara HSBC Life Insurance after the exit of its third partner, PNB.[1]
IndiaFinancial Services
Is CANARA HSBC LIFE INS CO L Shariah compliant?
CANARA HSBC LIFE INS CO L is currently screened as Non-Compliant (Business Activity) under AAOIFI Shariah Standard No. 21. Business activity in non-permissible sector: /\bfinancial services\b/i Debt to Market Cap (2.02%) complies with AAOIFI threshold (≤ 33%).
What is CANARA HSBC LIFE INS CO L's current valuation relative to peers?
CANARA HSBC LIFE INS CO L trades at a P/E of 92.5x compared to the sector median of 16.5x, and a Price-to-Book of 7.6x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.15x. Interest coverage is comfortable.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.